Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice

BACKGROUND: Therapeutic idiotypic (Id) vaccination is an experimental treatment for selected B cell malignancies. A broader use of Id-based vaccination, however, is hampered by the complexity and costs due to the individualized production of protein vaccines. These limitations may be overcome by tar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ruffini, Pier Adelchi, Os, Audun, Dolcetti, Riccardo, Tjønnfjord, Geir E, Munthe, Ludvig A, Bogen, Bjarne
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119056/
https://ncbi.nlm.nih.gov/pubmed/25059102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-207
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items